Current Prices from Acumen Pharmaceuticals, Inc. - Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	ABOS	USD	13.06.2025 20:52	1,13 USD	1,13 USD

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
0,00 %	-6,61 %	7,62 %	-7,38 %	-44,06 %	-57,20 %	-94,38 %

Company Profile for Acumen Pharmaceuticals, Inc. - Common Stock Share

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.

Company Data

Name Acumen Pharmaceuticals, Inc. - Common Stock

Company Acumen Pharmaceuticals, Inc.

Symbol ABOS

Website https://acumenpharm.com

Primary Exchange

NASDAQ

ISIN US00509G2093

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Mr. Daniel J. O'Connell M.B.A.

Market Capitalization 53 Mio

Country United States of America

Currency USD

Employees 0,1 T

Address 427 Park Street, 22902 Charlottesville

IPO Date 2021-07-01

Ticker Symbols

Name	Symbol
NASDAQ	ABOS

More Shares

Investors who Acumen Pharmaceuticals, Inc. - Common Stock hold also have the following shares in their portfolio:

ASR NL 15/45 FLR Bond

NED. GASUNIE 06/21 MTN Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog